MILAN and NEW YORK, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: GNTA), a pioneer in immuno-oncology, today announced…
July 28, 2025 12:24 ET | Source: Can-Fite BioPharma Ltd. $5.0 million upfront with up to an additional $10.0 million…